Australia appears to be experience a groundbreaking therapy for excess weight: Retatrutide. This new dual agonist – working on both GLP-1 and GIP receptors – shows promising results in clinical studies, indicating substantial reductions in body fat. While approval hasn't occurred with Australian regulators, several individuals struggling weight… Read More